期刊文献+

张亚强治疗膀胱癌临床经验 被引量:9

Clinical Experiences of ZHANG Yaqiang in Treating Bladder Cancer
下载PDF
导出
摘要 膀胱癌是泌尿外科常见疾病,现代医学主要采用手术治疗,以及术后常规膀胱灌注化疗药物。中医药能够降低膀胱癌术后复发率及降低化疗药物引起的不良反应。张亚强认为膀胱癌病位在膀胱,涉及脾肾,属于本虚标实。本虚为脾肾亏虚、气血不充,标实为湿热、热毒、痰浊、瘀血。基本病机多为脾肾亏虚、湿热蕴结、痰瘀毒互结,遇正气不足时适时复发。故在治疗过程中应重视预防复发,临证中注重病证症结合、分期论治,权衡驱邪与扶正力度,重视脾胃功能以及气机的条畅。根据临床经验并结合膀胱肿瘤特点创制消癥汤,药物配伍体现了中医扶正培本、祛邪不伤正的原则,临床证明可有效预防膀胱癌患者术后复发。 Bladder cancer is a common disease in urology. The main method is operation in modern medicine and using intravesical instillation of chemotherapeutics. Chinese medicine can prevent the recur- rence of bladder cancer after operation and reduce the side effects of chemotherapeutics. ZHANG Yaqiang regards that the disease locates in the bladder,involving the spleen and kidneys,belonging to root deficiency and branch excess. Root deficiency includes spleen-kidney insufficiency,Qi and blood insufficiency. Branch excess includes damp-heat,toxic heat,phlegm and blood stasis. So the basic pathogenesis of bladder cancer is insufficiency of the spleen and kidneys ,the accumulation of damp and heat ,the retention of phlegm,blood stasis and toxicity which causing the recurrence in case of healthy Qi insufficiency,So in the clinic we should focus on the recurrence ,combine the symptoms,disease and syndrome,differentiate the stages. Atten- tion should be paid to the conditions of healthy Qi and pathogenic factors,the functions of spleen and stomach and the smoothness of Qi circulation. Xiaozheng decoction with the functions of supplementing the healthy Qi and dispelling the pathogenic factors should after operation effectively in the clinical practice. be used to prevent the recurrence of bladder cancer
出处 《山东中医药大学学报》 2016年第3期253-255,共3页 Journal of Shandong University of Traditional Chinese Medicine
基金 全国名老中医药专家传承工作室建设项目(2014年度)
关键词 膀胱癌 中医药治疗 驱邪扶正 名医经验 张亚强 baldder cancer treatment of Chinese medicine supplementing the healthy Qi and dispelling thepathogenic factors doctor' s experience ZHANG Yaqiang
  • 相关文献

参考文献4

二级参考文献11

  • 1李季泓.黄芪的药理作用研究[J].辽宁中医药大学学报,2009,11(4):188-189. 被引量:72
  • 2叶章群,余虓,杨为民.喜树碱诱导人膀胱癌细胞RT4和MGH凋亡的实验研究[J].中华实验外科杂志,2005,22(2):183-185. 被引量:6
  • 3范海涛,李志,朱德淳,刘禄成,郑红淑,刘险峰.10-羟基喜树碱对人膀胱癌细胞增殖、侵袭的抑制作用及诱导凋亡的研究[J].生命科学研究,2005,9(1):90-94. 被引量:13
  • 4季宇彬.中药有效成分药理与应用[M].哈尔滨:黑龙江科学技术出版社,1994.294.
  • 5Brausi M, Collette L, Kurth K. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies[J]. Eur Urol, 2002, 41:523-531.
  • 6Sylvester RJ, Oosterlinck W,Van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials [ J ]. J Urol, 2004,171 (6 Pt 1):2186-2190.
  • 7BrausiM, Collette L, Kurth K. Variability in the recurence rate at first follow-up cystoscopy after TUR in stage Ta TI transitional cell carcinoma of the bladder a combined analysis of seven EORTC studies [ J ]. Eurol, 2002,41 : 523-531.
  • 8Sylvester R J, Oosterlinck W, Van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta TI bladder cancer a meta-analysis of published results of randomized clinical trials[ J ]. J Urol, 2004,171 (6 Pt I) : 2186-2190.
  • 9Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies [ J ]. European Urology, 2002, 41(5) : 523-531.
  • 10程鸿鸣,陈宗福,李虹,张卫东,张思孝.羟基喜树碱灌注预防膀胱癌术后复发(附86例报告)[J].临床泌尿外科杂志,2000,15(2):62-63. 被引量:25

共引文献20

同被引文献86

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部